Influence of L-arginine on the Expression of eNOS and COX2 in Experimental Pulmonary Thromboembolism
The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatme...
Saved in:
Published in | Journal of Huazhong University of Science and Technology. Medical sciences Vol. 26; no. 5; pp. 524 - 527 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
China
Department of Pulmonary Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, China%Department of Pulmonary Medicine, Affiliated Hospital of Wuhan University of Science & Technology, Wuhan 430064, China
2006
|
Subjects | |
Online Access | Get full text |
ISSN | 1672-0733 1993-1352 |
DOI | 10.1007/s11596-006-0509-4 |
Cover
Abstract | The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatment group. Pulmonary thromboembolism models were established by auto-blood back transfusion, and L-Arg 100 mg/kg was intraperitoneally injected after successful model preparation. The animals were sacrificed at 3 h, 1 day, 3 days and 7 days after embolism. Plasma NO, TXB2 and 6-Keto-PGF1 α were detected. The expression of eNOS and COX2 protein and mRNA in pulmonary tissues was detected by immunohistochemistry and RT-PCR respectively. The results showed that pulmonary thrombosis could be seen post pulmonary embolism and inflammatory reaction was significant. Plasma NO was decreased (P〈0.01), and the levels of TXB2, 6-Keto-PGF1α and T/P ratio were all elevated. The expression of eNOS protein and mRNA in the pulmonary tissue was down-regulated (P〈0.05), while that of COX2 protein and mRNA was upregulated (P〈0.01). In treatment group, the level of NO was increased, the levels of TXB2 and T/P ratio were decreased, but the level of 6-Keto-PGF1 α was increased. The expression of eNOS protein and mRNA in pulmonary tissue was upregulated (P〈0.05), while that of COX2 protein and mRNA was down-regulated (P〈0.05). In conclusion, L-arginine can educe the role of pulmonary tissue protection through up-regulating the expression of intra-pulmonary NOS and down -regulating COX2 in pulmonary thromboembolism. |
---|---|
AbstractList | The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatment group. Pulmonary thromboembolism models were established by auto-blood back transfusion, and L-Arg 100 mg/kg was intraperitoneally injected after successful model preparation. The animals were sacrificed at 3 h, 1 day, 3 days and 7 days after embolism. Plasma NO, TXB2 and 6-Keto-PGFla were detected. The expression of eNOS and COX2 protein and mRNA in pulmonary tissues was detected by immunohistochemistry and RT-PCR respectively. The results showed that pulmonary thrombosis could be seen post pulmonary embolism and inflammatory reaction was significant. Plasma NO was decreased (P<0.01), and the levels of TXB2, 6-Keto-PGF1alpha and T/P ratio were all elevated. The expression of eNOS protein and mRNA in the pulmonary tissue was down-regulated (P<0.05), while that of COX2 protein and mRNA was upregulated (P<0.01). In treatment group, the level of NO was increased, the levels of TXB2 and T/P ratio were decreased, but the level of 6-Keto-PGF1alpha was increased. The expression of eNOS protein and mRNA in pulmonary tissue was upregulated (P<0.05), while that of COX2 protein and mRNA was down-regulated (P<0.05). In conclusion, L-arginine can educe the role of pulmonary tissue protection through up-regulating the expression of intra-pulmonary NOS and down -regulating COX2 in pulmonary thromboembolism.The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatment group. Pulmonary thromboembolism models were established by auto-blood back transfusion, and L-Arg 100 mg/kg was intraperitoneally injected after successful model preparation. The animals were sacrificed at 3 h, 1 day, 3 days and 7 days after embolism. Plasma NO, TXB2 and 6-Keto-PGFla were detected. The expression of eNOS and COX2 protein and mRNA in pulmonary tissues was detected by immunohistochemistry and RT-PCR respectively. The results showed that pulmonary thrombosis could be seen post pulmonary embolism and inflammatory reaction was significant. Plasma NO was decreased (P<0.01), and the levels of TXB2, 6-Keto-PGF1alpha and T/P ratio were all elevated. The expression of eNOS protein and mRNA in the pulmonary tissue was down-regulated (P<0.05), while that of COX2 protein and mRNA was upregulated (P<0.01). In treatment group, the level of NO was increased, the levels of TXB2 and T/P ratio were decreased, but the level of 6-Keto-PGF1alpha was increased. The expression of eNOS protein and mRNA in pulmonary tissue was upregulated (P<0.05), while that of COX2 protein and mRNA was down-regulated (P<0.05). In conclusion, L-arginine can educe the role of pulmonary tissue protection through up-regulating the expression of intra-pulmonary NOS and down -regulating COX2 in pulmonary thromboembolism. R3; The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatment group. Pulmonary thromboembolism models were established by auto-blood back transfusion, and L-Arg 100 mg/kg was intraperitoneally injected after successful model preparation. The animals were sacrificed at 3 h, 1 day, 3 days and 7 days after embolism.Plasma NO, TXB2 and 6-Keto-PGF1α were detected. The expression of eNOS and COX2 protein and mRNA in pulmonary tissues was detected by immunohistochemistry and RT-PCR respectively.The results showed that pulmonary thrombosis could be seen post pulmonary embolism and inflammatory reaction was significant. Plasma NO was decreased (P<0.01), and the levels of TXB2,6-Keto-PGF1α and T/P ratio were all elevated. The expression of eNOS protein and mRNA in the pulmonary tissue was down-regulated (P<0.05), while that of COX2 protein and mRNA was upregulated (P<0.01). In treatment group, the level of NO was increased, the levels of TXB2 and T/P ratio were decreased, but the level of 6-Keto-PGF1 α was increased. The expression of eNOS protein and mRNA in pulmonary tissue was upregulated (P<0.05), while that of COX2 protein and mRNA was down-regulated (P<0.05). In conclusion, L-arginine can educe the role of pulmonary tissue protection through up-regulating the expression of intra-pulmonary NOS and down -regulating COX2 in pulmonary thromboembolism. The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatment group. Pulmonary thromboembolism models were established by auto-blood back transfusion, and L-Arg 100 mg/kg was intraperitoneally injected after successful model preparation. The animals were sacrificed at 3 h, 1 day, 3 days and 7 days after embolism. Plasma NO, TXB2 and 6-Keto-PGFla were detected. The expression of eNOS and COX2 protein and mRNA in pulmonary tissues was detected by immunohistochemistry and RT-PCR respectively. The results showed that pulmonary thrombosis could be seen post pulmonary embolism and inflammatory reaction was significant. Plasma NO was decreased (P<0.01), and the levels of TXB2, 6-Keto-PGF1alpha and T/P ratio were all elevated. The expression of eNOS protein and mRNA in the pulmonary tissue was down-regulated (P<0.05), while that of COX2 protein and mRNA was upregulated (P<0.01). In treatment group, the level of NO was increased, the levels of TXB2 and T/P ratio were decreased, but the level of 6-Keto-PGF1alpha was increased. The expression of eNOS protein and mRNA in pulmonary tissue was upregulated (P<0.05), while that of COX2 protein and mRNA was down-regulated (P<0.05). In conclusion, L-arginine can educe the role of pulmonary tissue protection through up-regulating the expression of intra-pulmonary NOS and down -regulating COX2 in pulmonary thromboembolism. The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and the action mechanism on pulmonary thromboembolism was explored. Wistar rats were randomly divided into control group, model group and treatment group. Pulmonary thromboembolism models were established by auto-blood back transfusion, and L-Arg 100 mg/kg was intraperitoneally injected after successful model preparation. The animals were sacrificed at 3 h, 1 day, 3 days and 7 days after embolism. Plasma NO, TXB2 and 6-Keto-PGF1 α were detected. The expression of eNOS and COX2 protein and mRNA in pulmonary tissues was detected by immunohistochemistry and RT-PCR respectively. The results showed that pulmonary thrombosis could be seen post pulmonary embolism and inflammatory reaction was significant. Plasma NO was decreased (P〈0.01), and the levels of TXB2, 6-Keto-PGF1α and T/P ratio were all elevated. The expression of eNOS protein and mRNA in the pulmonary tissue was down-regulated (P〈0.05), while that of COX2 protein and mRNA was upregulated (P〈0.01). In treatment group, the level of NO was increased, the levels of TXB2 and T/P ratio were decreased, but the level of 6-Keto-PGF1 α was increased. The expression of eNOS protein and mRNA in pulmonary tissue was upregulated (P〈0.05), while that of COX2 protein and mRNA was down-regulated (P〈0.05). In conclusion, L-arginine can educe the role of pulmonary tissue protection through up-regulating the expression of intra-pulmonary NOS and down -regulating COX2 in pulmonary thromboembolism. |
Author | 张建初 夏蕾 张晓菊 杨卫兵 白明 |
AuthorAffiliation | Department of Pulmonary Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China Department of Pulmonary Medicine, Affiliated Hospital of Wuhan University of Science & Technology, Wuhan 430064, China |
AuthorAffiliation_xml | – name: Department of Pulmonary Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, China%Department of Pulmonary Medicine, Affiliated Hospital of Wuhan University of Science & Technology, Wuhan 430064, China |
Author_xml | – sequence: 1 fullname: 张建初 夏蕾 张晓菊 杨卫兵 白明 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17219957$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU2P0zAQhi20iP2AH8AFRVw4rAL-SOL4iKplWamiSPTAzXL80brr2F07Ed1_z1QtQuLAYWSP5pkZve9co4uYokXoLcEfCcb8UyGkFV2NMUSLRd28QFdECFYT1tIL-Hec1pgzdomuS9lh3PKONq_QJeEUuJZfIfMQXZht1LZKrlrWKm989BGyWE1bW90d9tmW4iGFuv22-lGpaKrF6ietfDyWbfajjZMK1fc5jCmq_FyttzmNQ7IQwZfxNXrpVCj2zfm9Qesvd-vF13q5un9YfF7WmvJe1IQap4Vipu9VMxgxUE5MJxy1vREtJa5T2HW94lyrYWCqUawh2nQOt0ZTw27Q7WnsLxWdihu5S3OOsFBOu-dHczgM0lIwC7zCAugPJ3qf09NsyyRHX7QNQUWb5iI5DG_6XjRAvjuT8zBaI_egGFTKPy4CQE6AzqmUbN1fBMvjpeTpUhKWy-Ol5HEo_6dH-0lNYPSUlQ__7Xx_7tymuHnyIHRQ-tH5YCVllDagkf0GacKizw |
CitedBy_id | crossref_primary_10_1016_j_intimp_2015_07_044 crossref_primary_10_1007_s00603_012_0228_z crossref_primary_10_1155_2020_8718321 crossref_primary_10_1016_j_pathophys_2008_11_003 |
Cites_doi | 10.1159/000068427 10.1161/01.ATV.15.2.258 10.1016/j.niox.2004.10.009 10.1016/S0003-4975(01)03265-9 10.1097/00005344-199702000-00020 |
ClassificationCodes | R3 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.1007/s11596-006-0509-4 |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
DocumentTitleAlternate | Influence of L-arginine on the Expression of eNOS and COX2 in Experimental Pulmonary Thromboembolism |
EISSN | 1993-1352 |
EndPage | 527 |
ExternalDocumentID | tjykdxxb_e200605009 17219957 10_1007_s11596_006_0509_4 23224200 |
Genre | Journal Article |
GroupedDBID | -5E -5G -BR -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 29K 29~ 2B. 2C~ 2J2 2JN 2KG 2KM 2LR 2RA 2~H 30V 4.4 408 40D 40E 53G 5GY 5VS 6NX 8TC 8UJ 92F 92I 92L 95- 95. 95~ 96X AAAVM AABHQ AAJKR AANXM AARHV AARTL AAYIU AAYQN AAYTO ABFTV ABJOX ABKCH ABMNI ABNWP ABQBU ABTMW ACGFS ACHXU ACKNC ACOMO ACSNA ACUDM ADHIR ADINQ ADKPE ADURQ ADYFF ADZKW AEBTG AEGNC AEJHL AEKMD AEOHA AEPYU AETLH AEXYK AFWTZ AFZKB AGAYW AGDGC AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIIXL AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP ARMRJ AZFZN B-. BA0 BGNMA CAG CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 D-I EBS EJD ESBYG FA0 FEDTE FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GQ6 GQ7 H13 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IPNFZ IXD I~X I~Z J-C JBSCW JUIAU KOV M4Y MA- N2Q NDZJH NQJWS NU0 O9- O93 O9I O9J P9S PF0 QOR QOS R-E R89 R9I RIG ROL RPX RSV S.. S16 S1Z S27 S37 S3B SAP SCL SDH SHX SMD SNE SNX SOJ SPISZ SZ9 SZN T13 TCJ TGQ TSG TT1 TUC U2A U9L UG4 VC2 W48 W91 WK8 Z7U Z82 Z8V ZOVNA ~A9 ~WA AAYXX ABJNI ABQSL ADHKG AGQPQ CITATION DPUIP CGR CUY CVF ECM EIF NPM 7X8 4A8 93N PSX |
ID | FETCH-LOGICAL-c2789-12dfc9a3d88a4bd9b271d69f2e8d9521f6a0f68a77cabb3a4a341cd6f05dc2d3 |
ISSN | 1672-0733 |
IngestDate | Thu May 29 04:06:47 EDT 2025 Fri Jul 11 16:06:33 EDT 2025 Thu Jan 02 22:20:20 EST 2025 Thu Apr 24 23:07:40 EDT 2025 Wed Oct 01 00:35:44 EDT 2025 Fri Nov 25 17:01:34 EST 2022 |
IsPeerReviewed | false |
IsScholarly | false |
Issue | 5 |
Keywords | cyclooxygenase2 pulmonary thromboembolism nitric oxide synthase L-arginine |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2789-12dfc9a3d88a4bd9b271d69f2e8d9521f6a0f68a77cabb3a4a341cd6f05dc2d3 |
Notes | 42-1679/R R563 cyclooxygenase2 pulmonary thromboembolism nitric oxide synthase L-arginine pulmonary thromboembolism; L-arginine; nitric oxide synthase; cyclooxygenase2 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 17219957 |
PQID | 734148894 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | wanfang_journals_tjykdxxb_e200605009 proquest_miscellaneous_734148894 pubmed_primary_17219957 crossref_primary_10_1007_s11596_006_0509_4 crossref_citationtrail_10_1007_s11596_006_0509_4 chongqing_backfile_23224200 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2006-00-00 |
PublicationDateYYYYMMDD | 2006-01-01 |
PublicationDate_xml | – year: 2006 text: 2006-00-00 |
PublicationDecade | 2000 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Journal of Huazhong University of Science and Technology. Medical sciences |
PublicationTitleAlternate | Journal of Zuazhong University of Science and Technology: Medical Edition |
PublicationTitle_FL | JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCE) |
PublicationYear | 2006 |
Publisher | Department of Pulmonary Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, China%Department of Pulmonary Medicine, Affiliated Hospital of Wuhan University of Science & Technology, Wuhan 430064, China |
Publisher_xml | – name: Department of Pulmonary Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, China%Department of Pulmonary Medicine, Affiliated Hospital of Wuhan University of Science & Technology, Wuhan 430064, China |
References | G. Trummer (509_CR4) 2002; 73 C. Kroegel (509_CR1) 2003; 70 Q. D. Wang (509_CR5) 1999; 29 D. C. Souza-Costa (509_CR2) 2005; 12 T. W. Wakefield (509_CR3) 1995; 15 12584387 - Respiration. 2003 Jan-Feb;70(1):7-30 7749835 - Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):258-68 9057081 - J Cardiovasc Pharmacol. 1997 Feb;29(2):291-6 15631942 - Nitric Oxide. 2005 Feb;12 (1):9-14 11996278 - Ann Thorac Surg. 2002 Apr;73(4):1299-301 |
References_xml | – volume: 70 start-page: 7 year: 2003 ident: 509_CR1 publication-title: Respiration doi: 10.1159/000068427 – volume: 15 start-page: 258 issue: 2 year: 1995 ident: 509_CR3 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.15.2.258 – volume: 12 start-page: 9 issue: 1 year: 2005 ident: 509_CR2 publication-title: Nitric Oxide doi: 10.1016/j.niox.2004.10.009 – volume: 73 start-page: 1299 issue: 4 year: 2002 ident: 509_CR4 publication-title: Ann Thorac Surg doi: 10.1016/S0003-4975(01)03265-9 – volume: 29 start-page: 291 issue: 2 year: 1999 ident: 509_CR5 publication-title: J Cardiovasc Pharmacol doi: 10.1097/00005344-199702000-00020 – reference: 11996278 - Ann Thorac Surg. 2002 Apr;73(4):1299-301 – reference: 7749835 - Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):258-68 – reference: 12584387 - Respiration. 2003 Jan-Feb;70(1):7-30 – reference: 15631942 - Nitric Oxide. 2005 Feb;12 (1):9-14 – reference: 9057081 - J Cardiovasc Pharmacol. 1997 Feb;29(2):291-6 |
SSID | ssj0057624 |
Score | 1.3962114 |
Snippet | The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism... The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism and... R3; The influence of L-arginine on endothelial nitric oxide synthase (eNOS) and cyclooxygenase 2 (COX2) was observed in experimental pulmonary thromboembolism... |
SourceID | wanfang proquest pubmed crossref chongqing |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 524 |
SubjectTerms | Animals Arginine - pharmacology Arginine - therapeutic use Cyclooxygenase 2 - genetics Cyclooxygenase 2 - metabolism Female L-精氨酸 Lung - enzymology Male Nitric Oxide Synthase Type III - genetics Nitric Oxide Synthase Type III - metabolism Pulmonary Embolism - drug therapy Pulmonary Embolism - enzymology Rats Rats, Wistar RNA, Messenger - genetics RNA, Messenger - metabolism 基因表达 肺血管栓塞 |
Title | Influence of L-arginine on the Expression of eNOS and COX2 in Experimental Pulmonary Thromboembolism |
URI | http://lib.cqvip.com/qk/85740A/20065/23224200.html https://www.ncbi.nlm.nih.gov/pubmed/17219957 https://www.proquest.com/docview/734148894 https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200605009 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLINK - Czech Republic Consortium customDbUrl: eissn: 1993-1352 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0057624 issn: 1672-0733 databaseCode: AGYKE dateStart: 19970101 isFulltext: true titleUrlDefault: http://link.springer.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1993-1352 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0057624 issn: 1672-0733 databaseCode: U2A dateStart: 20020101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db5swEEdd97KXadO-sm6TH-qXVUyEgA2PkNK11dpOWqpme0HGQEKbwZYGqeu_u39kd4CBtNXU7SERcs7gcD7fz-f70LRtYUonMq1Ux9xhusVipgtbCN2QcSpgxyWNFA36R8ds_9Q6nNrTjQe_e15L5Sr6IK_vjCv5H65CG_AVo2T_gbPtTaEBroG_8A0chu978fhAVRipLP26WM6w3EPSHABgGuPay7WChMnxyZfqqGB8MjXRzBH0k_t_LhcwbHShm8yXxfeoSOCzUPkFG_RKA5s6u9QJaGBR36HeLg049Th1hzRg1PHQbwJoPAsb8WKXeqx3UdF4Ng32qD-mjlPdcEx9v0fjUMen_hBb_ID6HHu50JHjsxy36lV3b20Y3_a94487h2ifmZeqcXrg7XxKsnWaaSaK85bkKzadJVmk9Hdr_ui8V0BdL1fKY6J7S0eNTwJOUcDt8IpVBZZKAop8dp61p2CNdaZS86W4nmN9p3WPGLXEIn-60w7ocFbOYQW2RoiCaveIDKP47PuMy0vTbAGiB3sKNTgkrm959_NxIVh7_k43AGa1A-ipMsbRr7hOM6J0XZ2doJFpu6e47DqSvcFAdp2v4ZZ6NZpwc8DATK9sUTYWKeywROvhuTr_dRFfXUVhgkwDMgyyfWhygIOgdE5NT8El2O_WlafVcJXrQRXfeuNBmAAFefQTpsU6kLy1O6yC8PJU5LMeXpw80R43Gz3i1VL7VNtI8mda3EosKVLSSSwpcgISSzqJxd9RYgnMCIISS7Kc9CWWtDwnNyT2uTbZCybjfb2pc6JLjEPXh2acSleMYscRVhS7kcmHMXNTM3FiF-B1yoSRMkdwLkUUjYQlAHrKmKWGHUszHr3QNvMiT15pRDKO6bQsK0qZZceGSFzh2kLGQzFKuCkH2lb7_gAmywtM_hbCpgqAumEMNEO90VA2FQKwUM0i7HKbI0PCyhcWGBJaA-192-VHnR7nb8REsSkEJYYnkyJPivIy5PCHAEm4QPKyZl93N25iFgk-0LYbfobNCnwZ3jHJXt-PbEt71NlS32ibq2WZvIXdxSp6V83OP7PgFhs |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+L-arginine+on+the+Expression+of+eNOS+and+COX2+in+Experimental+Pulmonary+Thromboembolism&rft.jtitle=%E5%8D%8E%E4%B8%AD%E7%A7%91%E6%8A%80%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5%EF%BC%88%E5%8C%BB%E5%AD%A6%E8%8B%B1%E5%BE%B7%E6%96%87%E7%89%88%EF%BC%89&rft.au=ZHANG+Jianchu&rft.au=XIA+Lei&rft.au=ZHANG+Xiaoju&rft.au=YANG+Weibing&rft.date=2006&rft.pub=Department+of+Pulmonary+Medicine%2C+Union+Hospital%2C+Tongji+Medical+College%2C+Huazhong+University+of+Science+and+Technology%2CWuhan+430022%2C+China%25Department+of+Pulmonary+Medicine%2C+Affiliated+Hospital+of+Wuhan+University+of+Science+%26+Technology%2C+Wuhan+430064%2C+China&rft.issn=1672-0733&rft.volume=26&rft.issue=5&rft.spage=524&rft.epage=527&rft_id=info:doi/10.1007%2Fs11596-006-0509-4&rft.externalDocID=tjykdxxb_e200605009 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg |